Ailing Wang

Jun 17, 2024 | academicradiology.org | Chao Xu |Zhihong Wang |Ailing Wang |Yunyan Zheng |Guang Yang |Mingping Ma | +1 more

The aim of this study was to ascertain whether the utilization of multiple b-value diffusion-weighted habitat imaging, a technique that depicts tumor heterogeneity, could aid in identifying breast cancer patients who would derive substantial benefit from neoadjuvant chemotherapy (NAC). This prospective study enrolled 143 women (II–III breast cancer), who underwent multi-b-value diffusion-weighted imaging (DWI) in 3-T magnetic resonance (MR) before NAC.